AUSTIN, TX: Vermillion, a diagnostics company, has selected Liolios Group to handle IR and financial communications.
The agency will refresh and execute Vermillion's message to key stakeholders. The firm will support the company's conference calls, road shows, and financial conferences targeted to key investors and influencers.
“Given the increasing adoption of our [Food & Drug Administration-approved] OVA1 blood test and the recent positive results from our peripheral artery disease blood test study, Vermillion has made solid progress since the beginning of the year,” said Gail Page, president and CEO of Vermillion, in a statement. "It has now become especially important for a team of experienced IR professionals like Liolios Group to help us effectively communicate this message to our shareholders and raise awareness of Vermillion in the investment community."